Boehringer Ingelheim and Novozymes ally to create probiotics for poultry

Boehringer Ingelheim has announced a new collaboration with Novozymes in the field of probiotics for poultry hatcheries.

The companies will work to develop and commercialise probiotics for global poultry production, with Boehringer Ingelheim to market and distribute Novozymes' FloraMax probiotic product for the US poultry industry, before expanding to other countries in the coming years.

Probiotics are naturally occurring, live microbes that improve the gut flora of poultry and other animals, enhancing their overall health and offering a natural alternative to antibiotic growth promoters.

Given the rising global consumption of meat, coupled with legislative and consumer-driven curbs on the use of antibiotics as growth promoters in animal farming, it is expected that global demand for alternatives such as probiotics will continue to rise.

George Heidgerken, global head of livestock at Boehringer Ingelheim, said: "Collaborating with Novozymes enables Boehringer Ingelheim to enter an exciting new segment of products to provide alternatives in an environment that is increasingly challenged by antibiotic bans."

Boehringer Ingelheim's close relationships with large-scale producers are expected to give Novozymes improved access to new distribution channels and customers.

With over 20 years of experience within the animal health market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current animal health roles we have available, you can search for the latest job roles, register your details, or contact the team today.